Advisory Board January 9, 2025

In an interview with STAT’s Matthew Herper, FDA Commissioner Robert Califf reflected on his time leading the agency and explained why he’s “concerned” about what could happen during the incoming Trump administration.

Radio Advisory: What will happen in healthcare following the election?

Califf looks back on his time as FDA commissioner

In the interview, Califf said that his confirmation as FDA commissioner in February 2022, which was the second time he had been confirmed to the post, was “a pretty low time.”

“As the waves came through on Covid, the constant realization that people were dying who didn’t need to, if they just took the vaccine, was really wearing,” he said.

On Califf’s first day as commissioner, Abbott announced a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Interview / Q&A, Trends
A flurry of health tech deals announced ahead of JPM
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
FDA offers new draft guidance to developers of AI-enabled medical devices
Chevron’s Fall And Its Impact On Medical AI
5 FDA decisions to watch in the first quarter of 2025

Share This Article